County

Spokane County EMS

May be outdated170 dose entries41 drugs1 documentSpokane, WAeffective 2022-07-0198% machine-parsed of 170

Spokane County EMS (Spokane, WA) carries 41 drugs across 170 dose entries in its current published protocol, effective 2022-07-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses41

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1000 mg	IV	not captured	standing	page 331
Other	adult	650 mg	PO	not captured	standing	page 331
Other	peds	15 mg/kg	IV	not captured	standing	page 331

Activated Charcoal

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	50 g	PO	not captured	standing	page 333
Other	peds	1 g/kg	PO	not captured	standing	page 333

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	page 334
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 334

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5 mg	NEB	not captured	standing	page 335
Other	adult	5 mg	NEB	not captured	standing	page 335
Other	peds	2.5 mg	NEB	not captured	standing	page 335
Other	peds	2.5 mg	NEB	not captured	standing	page 335

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	150 mg	IV	not captured	standing	page 336
Other	adult	150 mg	IV	not captured	standing	page 336
Other	adult	300 mg	IV/IO	not captured	standing	page 336
Other	peds	5 mg/kg	IV/IO	not captured	standing	page 336
Other	peds	5 mg/kg	IV	not captured	standing	page 336
Other	peds	5 mg/kg	IV	not captured	standing	page 336

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	160–325 mg	PO	not captured	standing	page 332

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	1 mg	IV/IO	not captured	standing	page 337
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	page 337
Nerve agent exposure	adult	MDV or Mark 1 Kit(s) (1-3 doses)	IV/IO/IM	not captured	standing	page 337
Nerve agent exposure	peds	0.05–0.1 mg/kg	IV/IO/IM	not captured	standing	page 337

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20 mL	IV/IO	not captured	standing	page 338
Other	adult	20 mL	IV/IO	not captured	standing	page 338
Other	adult	20 mL	IV/IO	not captured	standing	page 338

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	25 g	IV/IO	not captured	standing	pages 329, 330
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	pages 329, 330

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–10 mg	IV/IM	not captured	standing	page 339
Other	peds	0.2–0.5 mg/kg	IV/IM	not captured	standing	page 339

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–15 mg	IV	not captured	standing	page 340

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 341
Allergic reaction	adult	25–50 mg	IV/IM	not captured	standing	page 341
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 341
Allergic reaction	peds	1 mg/kg	IV/IM	not captured	standing	page 341
Anaphylaxis	adult	50 mg	IV/IO	not captured	standing	page 341
Anaphylaxis	peds	1 mg/kg	IV/IO	not captured	standing	page 341

Droperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	0.625–1.25 mg	IV/IO/IM	not captured	standing	page 342
Nausea / vomiting	peds	0.01 mg/kg	IV/IO/IM	not captured	standing	page 342
Other	adult	5–10 mg	IV/IO/IM	not captured	standing	page 342
Other	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 342

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 343, 344
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	pages 343, 344
Asthma / bronchospasm	adult	0.3 mg	IM	not captured	standing	pages 343, 344
Asthma / bronchospasm	peds	0.01 mg/kg	IM	not captured	standing	pages 343, 344
Asystole / PEA	adult	1 mg	IV/IO	not captured	standing	pages 343, 344
Asystole / PEA	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 343, 344
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	pages 343, 344
VF / pulseless VT	adult	1 mg	IV/IO	not captured	standing	pages 343, 344
VF / pulseless VT	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 343, 344

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.3 mg/kg	IV/IO	not captured	standing	page 345
Other	peds	0.3 mg/kg	IV/IO	not captured	standing	page 345
Procedural sedation	adult	0.1 mg/kg	IV/IO	not captured	standing	page 345
Procedural sedation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 345

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mcg/kg	IV/IO/IM	not captured	standing	page 346
Severe pain	adult	0.5–1 mcg/kg	IV/IO/IM	not captured	standing	page 346
Severe pain	adult	1.5 mcg/kg	IN	not captured	standing	page 346
Severe pain	peds	0.5 mcg/kg	IV/IO/IM	not captured	standing	page 346
Severe pain	peds	1.5 mcg/kg	IN	not captured	standing	page 346

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	3–10 mg	IV/IO	not captured	standing	page 347
Beta-blocker / calcium-channel-blocker overdose	adult	3–10 mg	IV/IO	not captured	standing	page 347
Hypoglycemia	adult	1 mg	IM/SQ	not captured	standing	page 347
Hypoglycemia	peds	0.05 mg/kg	IM/SQ	not captured	standing	page 347

Heparin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	5000 unit	IV	not captured	standing	page 348
ACS / chest pain	adult	5000 unit	IV	not captured	standing	page 348
Other	adult	5000 unit	IV	not captured	standing	page 348
Other	adult	5000 unit	IV	not captured	standing	page 348

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	pages 349, 350
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	pages 349, 350

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	400 mg	PO	not captured	standing	page 351
Fever	peds	10 mg/kg	PO	not captured	standing	page 351
Mild to moderate pain	adult	400 mg	PO	not captured	standing	page 351
Mild to moderate pain	peds	10 mg/kg	PO	not captured	standing	page 351

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 352
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 352
Asthma / bronchospasm	peds	500 mcg	NEB	not captured	standing	page 352
Asthma / bronchospasm	peds	500 mcg	NEB	not captured	standing	page 352
Other	adult	500 mcg	NEB	not captured	standing	page 352
Other	adult	500 mcg	NEB	not captured	standing	page 352
Other	adult	500 mcg	NEB	not captured	standing	page 352
Other	peds	500 mcg	NEB	not captured	standing	page 352
Other	peds	500 mcg	NEB	not captured	standing	page 352
Other	peds	500 mcg	NEB	not captured	standing	page 352

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	4 mg/kg	IM	not captured	standing	pages 204, 353
Hyperactive delirium	peds	4 mg/kg	IM	not captured	standing	pages 204, 353
Other	adult	2 mg/kg	IV/IO	not captured	standing	page 353
Other	peds	1 mg/kg	IV/IO	not captured	standing	page 353
Mild to moderate pain	adult	0.2 mg/kg	IV/IO	not captured	standing	page 353
Mild to moderate pain	peds	0.2 mg/kg	IV/IO	not captured	standing	page 353
Post-intubation sedation	adult	1 mg/kg	IV/IO	not captured	standing	page 353
Post-intubation sedation	peds	1 mg/kg	IV/IO	not captured	standing	page 353

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.5–0.75 mg/kg	IV/IO	not captured	standing	pages 355, 356
Other	adult	20–40 mg	IV/IO	not captured	standing	pages 355, 356
Other	peds	0.25–0.5 mg/kg	IV/IO	not captured	standing	pages 355, 356
Other	peds	1 mg/kg	IV/IO	not captured	standing	pages 355, 356
Wide-complex tachycardia	adult	0.5–0.75 mg/kg	IV/IO	not captured	standing	pages 355, 356
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	pages 355, 356
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 355, 356
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 355, 356

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	4 mg	IV/IM	not captured	standing	page 216
Organophosphate poisoning	adult	4 mg	IV/IM	not captured	standing	page 216
Seizure	adult	1–2 mg	IV/IM	not captured	standing	page 357
Seizure	adult	1–2 mg	IO	not captured	standing	page 357
Seizure	peds	0.1 mg/kg	IV/IM	not captured	standing	page 357
Seizure	peds	0.1 mg/kg	IO	not captured	standing	page 357

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV/IO	not captured	standing	page 358
Asthma / bronchospasm	peds	50 mg/kg	IV/IO	not captured	standing	page 358
Other	adult	4 g	IV/IO	not captured	standing	page 358
Other	adult	4 g	IM	not captured	standing	page 358
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 358
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 358
VF / pulseless VT	peds	50 mg/kg	IV/IO	not captured	standing	page 358
VF / pulseless VT	peds	50 mg/kg	IV/IO	not captured	standing	page 358

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	125 mg	IV/IO	not captured	standing	page 359
Asthma / bronchospasm	peds	2 mg/kg	IV/IO	not captured	standing	page 359
COPD	adult	125 mg	IV/IO	not captured	standing	page 359
COPD	peds	2 mg/kg	IV/IO	not captured	standing	page 359

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	5 mg	IV/IO/IM/IN	not captured	standing	page 360
Hyperactive delirium	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 360
Other	adult	2.5 mg	IV/IO/IM/IN	not captured	standing	page 360
Other	adult	5 mg	IV/IO/IM/IN	not captured	standing	page 360
Other	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 360
Other	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 360
Procedural sedation	adult	5 mg	IV/IO/IM/IN	not captured	standing	page 360
Procedural sedation	adult	5 mg	IV/IO/IM/IN	not captured	standing	page 360
Procedural sedation	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 360
Procedural sedation	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 360
Seizure	adult	5 mg	IV/IO/IM/IN	not captured	standing	page 360
Seizure	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	page 360

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	2–6 mg	IV	not captured	standing	page 361
Severe pain	adult	5–15 mg	IM	not captured	standing	page 361
Severe pain	peds	1 mg	IV	not captured	standing	page 361
Severe pain	peds	1 mg	IM	not captured	standing	page 361

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.4 mg	IV/IO/IM	not captured	standing	page 362
Other	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 362
Other	peds	0.1 mg/kg	not captured	not captured	standing	pages 208, 362

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 363
Other	adult	0.4 mg	SL	not captured	standing	page 363

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiogenic shock	adult	2–30 mcg	IV	not captured	standing	pages 364, 365
Cardiogenic shock	peds	0.05–1 mcg/kg	IV	not captured	standing	pages 364, 365
Other	adult	2–30 mcg	IV	not captured	standing	pages 364, 365
Other	peds	0.05–1 mcg/kg	IV	not captured	standing	pages 364, 365

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	page 366
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	page 366

Oral Glucose Gel

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	page 367
Hypoglycemia	peds	0.5–1 g/kg	PO	not captured	standing	page 367

Oxymetazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 or 3 sprays	IN	not captured	standing	page 370
Other	adult	2 or 3 sprays	IN	not captured	standing	page 370

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	600–1800 mg	IV/IM	not captured	standing	pages 371, 372
Other	peds	25–50 mg/kg	IV/IM	not captured	standing	pages 371, 372

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	peds	0.5 mL	NEB	not captured	standing	page 373

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 mg/kg	IV	not captured	standing	page 374
Other	peds	1 mg/kg	IV	not captured	standing	page 374

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	1 mEq/kg	IV/IO	not captured	standing	page 375
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	page 375
Hypotension / shock	adult	1 mEq/kg	IV/IO	not captured	standing	page 375
Hypotension / shock	peds	1 mEq/kg	IV/IO	not captured	standing	page 375
Other	adult	1 mEq/kg	IV/IO	not captured	standing	page 375
Other	adult	1 mEq/kg	IV/IO	not captured	standing	page 375
Other	peds	1 mEq/kg	IV/IO	not captured	standing	page 375
Other	peds	1 mEq/kg	IV/IO	not captured	standing	page 375

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1.5 mg/kg	IV/IO	not captured	standing	page 376
Other	adult	3 mg/kg	IM	not captured	standing	page 376
Other	peds	1.5 mg/kg	IV/IO	not captured	standing	page 376
Other	peds	3 mg/kg	IM	not captured	standing	page 376

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	1 g	IV	not captured	standing	page 377
Other	adult	1 g	IV	not captured	standing	page 377
Other	adult	2.5 mL	IN	not captured	standing	page 377
Other	peds	15 mg/kg	IV	not captured	standing	page 377

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.1 mg/kg	IV	not captured	standing	page 378
Other	peds	0.1 mg/kg	IV	not captured	standing	page 378

Cite this

Spokane County EMS, United States EMS Protocol Census. 170 dose entries, effective 2022-07-01.

https://protoquiz.com/census/agencies/spokane-county-ems/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.